Benzinga - Thu, 06 May 2021 07:31:46 -0400
Benzinga - Thu, 15 Apr 2021 05:58:20 -0400
Benzinga - Wed, 14 Apr 2021 13:20:26 -0400
Benzinga - Wed, 14 Apr 2021 13:09:33 -0400
Benzinga - Wed, 14 Apr 2021 12:09:23 -0400
load more
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.190-0.290 -0.1000
REV19.800M18.702M-1.098M
Q4 2020Est.ActualSurprise
EPS-0.290
REV12.785M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
KYMRKymera Therapeutics7.49%2B

Kymera Therapeutics Company Questions & Answers

Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kymera Therapeutics's (KYMR) main competitors?

A

There are no as such competitors for Kymera Therapeutics.

Q

What is the target price for Kymera Therapeutics?

A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Berenberg on 2021-04-14. The analyst firm set a price target for 0.00 expecting KYMR to fall to within 12 months (a possible -100.00% downside). 9 analyst firms have reported ratings in the last year.

Q

How much is Kymera Therapeutics (KYMR) stock ?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $44.05 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Kymera Therapeutics (KYMR) dividend?

A

There are no upcoming dividends for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A
Kymera Therapeutics’s Q2 earnings are confirmed after-market from now on August 8, 2021.
Q

When is the upcoming split for KYMR?

A

There is no upcoming split for Kymera Therapeutics.